Compound Summary
Compound Name: | HOMATROPINE HYDROBROMIDE |
Compound CID: | 5821 |
Synonyms: | HOMATROPINE HYDROBROMIDE DL-Homatropine hydrobromide 51-56-9 Tropine mandelate hydrobromide SR-01000075900 More... |
Iupac Name: | (8-methyl-8-azabicyclo[3.2.1]octan-3-yl) 2-hydroxy-2-phenylacetate;hydrobromide |
InChI: | InChI=1S/C16H21NO3.BrH/c1-17-12-7-8-13(17)10-14(9-12)20-16(19)15(18)11-5-3-2-4-6-11;/h2-6,12-15,18H,7-10H2,1H3;1H |
InChIKey: | DWSGTFTVBLXELC-UHFFFAOYSA-N |
Canonical Smiles: | CN1C2CCC1CC(C2)OC(=O)C(C3=CC=CC=C3)O.Br |
Isomeric Smiles: | CN1C2CCC1CC(C2)OC(=O)C(C3=CC=CC=C3)O.Br |
Molecular Weight: | 356.25 |
Molecular Formula: | C16H22BrNO3 |
Molecular Weight: | 356.25 |
Molecular Formula: | C16H22BrNO3 |
Hydrogen Bond Donor Count: | 2 |
Hydrogen Bond Acceptor Count: | 4 |
Rotatable Bond Count: | 4 |
Heavy Atom Count: | 21 |
Complexity: | 340 |
HOMATROPINE HYDROBROMIDE | HOMATROPINE HYDROBROMIDE |
---|---|
HOMATROPINE HYDROBROMIDE |
DL-Homatropine hydrobromide |
51-56-9 |
Tropine mandelate hydrobromide |
SR-01000075900 |
C16H21NO3.HBr |
(1S,5R)-8-methyl-8-azabicyclo3.2.1oct-3-yl 2-hydroxy-2-phenylacetate, bromid e |
alpha-Hydroxybenzeneacetic acid 8-methyl-8-azabicyclo3.2.1oct-3-yl ester hydrobromide |
homatropinhydrobromid |
endo-8-Methyl-8-azabicyclo3.2.1octan-3-yl 2-hydroxy-2-phenylacetate hydrobromide |
Benzeneacetic acid, .alpha.-hydroxy-, (3-endo)-8-methyl-8-azabicyclo3.2.1oct-3-yl ester, hydrobromide (1:1) |
SCHEMBL41951 |
ARONIS24469 |
Tox21_500592 |
SBB056970 |
AKOS015964977 |
AKOS015998946 |
AC-1694 |
CCG-208522 |
LP00592 |
MCULE-8960409513 |
NCGC00093971-01 |
NCGC00093971-02 |
NCGC00093971-03 |
NCGC00094693-01 |
NCGC00094693-02 |
NCGC00261277-01 |
O601 |
DB-022458 |
EU-0100592 |
FT-0603222 |
ST50989943 |
H 0126 |
Q4142891 |
SR-01000075900-1 |
SR-01000075900-7 |
Homatropine hydrobromide, European Pharmacopoeia (EP) Reference Standard |
Endo-8-Methyl-8-azabicyclo3.2.1octan-3-yl-2-hydroxy-2-phenylacetate hydrobromide |
Homatropine hydrobromide, United States Pharmacopeia (USP) Reference Standard |
Species | Dosage | Unit | CG Lifespan(AVG/MED days) | TG Lifespan(AVG/MED days) | Lifespan Change(AVG/MED%) | CG Lifespan(MAX days) | TG Lifespan(MAX days) | Lifespan Change(MAX%) | Significant | Strain | Gender | PubMed | Active Label |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Caenorhabditis elegans | 33 | umol/L | -6 | NS | N2 | 24134630 | Inactive |
Species | Lifespan Change(AVG/MED%) | Lifespan Change(MAX%) | Count Reference | Count Data point |
---|---|---|---|---|
Caenorhabditis elegans | -6 | 1 | 1 |